跳至主要内容
临床试验/NCT06481007
NCT06481007尚未招募不适用

Algerian Cholecystectomy Outcomes and Determinants Study

University of Oran 10 个研究点目标入组 500 人开始时间: 2025年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
500
主要终点
Evaluate the 30-day mortality and morbidity

研究概览

简要总结

Cholecystectomy, the surgical removal of the gallbladder, is a common procedure performed to treat benign gallbladder diseases such as cholelithiasis (gallstones), cholecystitis (inflammation of the gallbladder), and biliary dyskinesia. While generally considered safe, this surgery can be associated with significant morbidity and mortality, particularly in certain populations or healthcare settings. Understanding these outcomes and the factors influencing them is crucial for improving patient care and surgical practices.

In Algeria, the healthcare landscape presents unique challenges and opportunities for evaluating surgical outcomes. Limited studies have specifically focused on the morbidity and mortality associated with cholecystectomy in this context. This study aims to fill that gap by providing comprehensive data on 30-day postoperative outcomes following cholecystectomy for benign gallbladder diseases in Algeria. Such data is essential for benchmarking current practices, identifying areas for improvement, and ultimately enhancing patient safety and surgical efficacy.

详细描述

This study seeks to bridge this knowledge gap by offering detailed data on 30-day postoperative outcomes after cholecystectomy for benign gallbladder diseases in Algeria. This information is crucial for benchmarking existing practices, pinpointing areas for enhancement, and ultimately improving patient safety and surgical effectiveness.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 years and older.
  • Undergoing cholecystectomy.
  • Surgery performed in public or private hospitals in Algeria.
  • Surgery performed from January 1, 2025, to June 30, 2025.

排除标准

  • Patients younger than 18 years.
  • Patients refusing to participate.
  • Cholecystectomy performed for Gallbladder cancer.
  • Cholecystectomy performed outside the inclusion period.
  • Cholecystectomies performed in conjunction with other major surgeries.

结局指标

主要结局

Evaluate the 30-day mortality and morbidity

时间窗: occuring in of before 30 day postopérative période.

Evaluation of rate of mortality and morbidity at 30 day

factors associated with 30-day morbidity and mortality

时间窗: occuring in of before 30 day postopérative période.

determinants of the occurence of complications and mortality on or before 30 day in postopérative period

次要结局

  • estimate the incidence of bile duct injuries following cholecystectomy for benign diseases(occuring in of before 30 day postopérative periode.)
  • assess surgical practices related to cholecystectomy in Algeria.(During surgical procedure ( Cholecystectomy))
  • estimate the incidence of incidental gallbladder cancer discovered during cholecystectomy in Algeria.(postoperative periode ( during or after surgical procedure))

研究者

发起方
University of Oran 1
申办方类型
Other
责任方
Principal Investigator
主要研究者

Anisse Tidjane

Professor

University of Oran 1

相似试验

ALgerian Cholecystectomy Outcomes and Determinants... | 临床试验